Heat Biologics Announces First Patient Treated in First-in-Human Clinical Trial of PTX-35 Jun 22, 2020
Heat Biologics Announces FDA Clearance of Investigational New Drug (IND) Application for PTX-35 Jun 8, 2020
Heat Biologics Presents Positive Survival Benefit for HS-110 in Combination with Nivolumab in Phase 2 Lung Cancer Trial at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting May 29, 2020
Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine May 27, 2020
Positive Survival Data from Phase 2 Lung Cancer Trial Accepted for Presentation at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting May 14, 2020
Heat Biologics Reports Progress on COVID-19 Efforts and Timeline of Anticipated Q2 2020 Milestones Apr 29, 2020
